Price $105.68 |
Market Cap
262.31B
|
Sector Health Care |
Div. Growth
4.60%
|
|
P/E
18.0
|
P/B
5.87
|
P/S
4.4
|
Dividend %
2.80%
|
|
P/CF
233.0
|
P/FCF
34.4
|
Op. Cash Flow
18.89M
|
FCF
2.9
|
|
Op. Margin
31.90%
|
Net Margin
28.00%
|
ROE
39.80%
|
ROI
15.50%
|
|
ROA
15.50%
|
EPS Growth
130.60%
|
Current Ratio
1.3
|
Debt/Equity
80.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Nevro Corp (NVRO) | $38.58 | - | - | 1.38B | Strong Buy |
| IM Cannabis Corp (IMCC) | $1.25 | - | - | 14M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.09 | - | - | 127.1M | Strong Buy |
| Sesen Bio Inc (SESN) | $0.60 | - | - | 119.2M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.40 | - | - | 20.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
